Current challenges and opportunities in treating glioblastoma

A Shergalis, A Bankhead, U Luesakul… - Pharmacological …, 2018 - ASPET
Glioblastoma multiforme (GBM), the most common and aggressive primary brain tumor, has
a high mortality rate despite extensive efforts to develop new treatments. GBM exhibits both …

[HTML][HTML] The hallmarks of glioblastoma: Heterogeneity, intercellular crosstalk and molecular signature of invasiveness and progression

F Torrisi, C Alberghina, S D'Aprile, AM Pavone… - Biomedicines, 2022 - mdpi.com
In 2021 the World Health Organization published the fifth and latest version of the Central
Nervous System tumors classification, which incorporates and summarizes a long list of …

[HTML][HTML] Recurrence-and malignant progression-associated biomarkers in low-grade gliomas and their roles in immunotherapy

C Teng, Y Zhu, Y Li, L Dai, Z Pan, S Wanggou… - Frontiers in …, 2022 - frontiersin.org
Despite a generally better prognosis than high-grade glioma (HGG), recurrence and
malignant progression are the main causes for the poor prognosis and difficulties in the …

[HTML][HTML] Downregulation of orosomucoid 2 acts as a prognostic factor associated with cancer-promoting pathways in liver cancer

HZ Zhu, WJ Zhou, YF Wan, K Ge, J Lu… - World journal of …, 2020 - ncbi.nlm.nih.gov
BACKGROUND Liver cancer has a high mortality and morbidity rate throughout the world. In
clinical practice, the prognosis of liver cancer patients is poor, and the complex reasons …

[HTML][HTML] Current understanding of gliomagenesis: from model to mechanism

J Luo, M Junaid, N Hamid, JJ Duan… - International Journal of …, 2022 - ncbi.nlm.nih.gov
Glioma, a kind of central nervous system (CNS) tumor, is hard to cure and accounts for 32%
of all CNS tumors. Establishing a stable glioma model is critically important to investigate the …

[HTML][HTML] Musashi1 contribution to glioblastoma development via regulation of a network of DNA replication, cell cycle and division genes

M Baroni, C Yi, S Choudhary, X Lei, A Kosti… - Cancers, 2021 - mdpi.com
Simple Summary Glioblastoma (GBM) is one of the most aggressive tumor types with no
effective treatment options. To create new routes for therapy, it is necessary to continue …

[HTML][HTML] RB1‑promoter methylation in glioblastoma: A rare event in glioblastoma

S Urbschat, G Breitfelder, M Henia… - Oncology …, 2023 - spandidos-publications.com
The retinoblastoma gene (RB1) is a tumor suppressor gene that serves a key role in the
development of numerous tumor diseases that can be downregulated by DNA methylation …

Disentangling the therapeutic tactics in GBM: From bench to bedside and beyond

S Daisy Precilla, SS Kuduvalli… - Cell Biology …, 2021 - Wiley Online Library
Glioblastoma multiforme (GBM) is one of the most common and malignant form of adult brain
tumor with a high mortality rate and dismal prognosis. The present standard treatment …

[HTML][HTML] Functional in vitro assessment of VEGFA/NOTCH2 signaling pathway and pRB proteasomal degradation and the clinical relevance of mucolipin TRPML2 …

G Santoni, C Amantini, M Nabissi, A Arcella… - International Journal of …, 2022 - mdpi.com
Glioblastoma (GBM) is the most malignant glioma with an extremely poor prognosis. It is
characterized by high vascularization and its growth depends on the formation of new blood …

Pisosterol induces G2/M cell cycle arrest and apoptosis via the ATM/ATR signaling pathway in human glioma cells

WAS Ferreira, RR Burbano… - Anti-Cancer Agents …, 2020 - ingentaconnect.com
Background: Pisosterol, a triterpene derived from Pisolithus tinctorius, exhibits potential
antitumor activity in various malignancies. However, the molecular mechanisms that mediate …